“Pain has a negative impact on the quality of life in cancer patients…
…we hypothesized that a cannabinoid receptor agonist might be a novel therapy for cancer pain. Taking into consideration the side effects of a CB1 receptor agonist (which limits their clinical application), we chose a CB2 receptor agonist to investigate its effect in cancer pain…
Recent clinical trials have demonstrated that cannabinoids may have significant positive effects in refractory chronic and cancer pain. The cannabinoids are thought to exert most of their effects by binding to G protein–coupled cannabinoid receptors, which include 2 cloned metabotropic receptors: cannabinoid (CB)1 and CB2…
CONCLUSION: These data indicated that intrathecal administration of cannabinoid receptor agonists might relieve cancer pain… These results also suggested that cannabinoids might be a useful alternative or adjunct therapy for relieving cancer pain.
The use of a CB2 receptor agonist could be a novel option for treatment of cancer pain.”
Somebody necessarily lend a hand to make seriously articles I’d state. This is the very first time I frequented your website page and so far? I amazed with the research you made to make this particular submit incredible. Wonderful task!